The U.S. Food and Drug Administration (FDA) has announced the recall of popular blood pressure medication Irbesartan, after finding an impurity that could cause cancer, months after it recalled Valsartan over similar reasons.
The agency discovered the pills contain N-nitrosodiethylamine (NDEA), classified as a potential human carcinogen. NDEA is used to make rocket fuel and is a byproduct of fish processing and the making of certain pesticides.
